EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methodology Assessment of Endoscopic Ultrasound Radiofrequency Ablation ( EUS ‐ RFA ) for Pancreatic Neoplasms: Results From an International Survey

Andrea Lisotti, Matteo Tacelli, Stefano Francesco Crinò, Graziella Masciangelo, Pietro Fusaroli, Marc Barthet, Nirav Thosani, Maria Cristina Conti Bellocchi, Sarah Leblanc, Tawfik Khoury iD, Paolo Giorgio Arcidiacono, Antonio Facciorusso iD und 15 weitere

Digestive Endoscopy · 2026

DOI: 10.1111/den.70212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Endoscopy, 2026. Verfasst von Andrea Lisotti und 26 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Digestive Endoscopy Unit, Imola Hospital, AUSL Imola, and Department of Medical and Surgical Sciences (DIMEC), University of Bol…. Hauptthemen laut MEDLINE: Endosonography, Pancreatic Neoplasms, Radiofrequency Ablation, Catheter Ablation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Endoscopic ultrasound‐guided radiofrequency ablation (EUS‐RFA) is increasingly used; however, clinical application remains unstandardized. We assessed real‐world practice among international users.

Methods

A cross‐sectional 70‐item survey was conducted. Results are presented descriptively (numbers, percentages).

Results

Overall, 91 of 175 invited physicians from Europe (74.4%), North America (13.3%), and Asia (12.2%) completed the survey. EUS‐RFA was performed by 94.1% of respondents for insulinoma, with heterogeneous responses for other indications. Most physicians (96.3%) performed EUS‐RFA under deep sedation or general anesthesia; marked variability was reported on antibiotic prophylaxis (57.5%), aggressive hydration (52.5%), generator power settings, ablation strategy, or probe selection. Lesions involving or located ≤ 1 mm from the main pancreatic duct were considered high risk by 97.5% and 85.0%, respectively, yet no standardized preventive strategy was identified. Post‐procedural management and follow‐up were heterogeneous, with a high proportion of responses for definitions of technical success (88.8%), clinical success in insulinoma (92.3%), and disease recurrence (97.5%), with high variability for definitions of partial ablation and post‐RFA pancreatitis.

Conclusions

Despite the global expansion of EUS‐RFA, clinical practice remains highly heterogeneous and geographically skewed. The lack of standardized methodology and terminology poses significant barriers to generating high‐quality evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndosonographyPancreatic NeoplasmsRadiofrequency AblationCatheter AblationPractice Patterns, Physicians'HumansCross-Sectional StudiesSurveys and QuestionnairesTreatment Outcome

Autor:innen und Institutionen

  • Gastroenterology and Digestive Endoscopy Unit, Imola Hospital, AUSL Imola, and Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
  • Department of Gastroenterology and Digestive Endoscopy, Hôpital Privé Jean Mermoz, Ramsay Santé, Lyon, France.
  • Pancreatobiliary Endoscopy and Endosonography Division, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
  • Department of Medicine, University of Verona, Verona, Italy.
  • Department of Gastroenterology and Digestive Endoscopy, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.
  • Division of Gastroenterology, Hepatology and Nutrition, McGovern Medical School at UTHealth, Houston, Texas, USA.

ORCID-Profile: Tawfik Khoury, Antonio Facciorusso, Takeshi Ogura, Khanh Do-Cong Pham

Zitieren

APA

Lisotti, A., Tacelli, M., Crinò, S. F., Masciangelo, G., Fusaroli, P., Barthet, M., Thosani, N., Conti Bellocchi, M. C., Leblanc, S., Khoury, T., Arcidiacono, P. G., Facciorusso, A., Caillol, F., Giovannini, M., Fuccio, L., Samanta, J., Teoh, A. Y. B., Ogura, T., Havre, R. F., …, & EUS‐RFA methodology study group (2026). Methodology Assessment of Endoscopic Ultrasound Radiofrequency Ablation ( EUS ‐ RFA ) for Pancreatic Neoplasms: Results From an International Survey. Digestive Endoscopy. https://doi.org/10.1111/den.70212

Vancouver

Lisotti A, Tacelli M, Crinò SF, Masciangelo G, Fusaroli P, Barthet M, et al. Methodology Assessment of Endoscopic Ultrasound Radiofrequency Ablation ( EUS ‐ RFA ) for Pancreatic Neoplasms: Results From an International Survey. Digestive Endoscopy. 2026. doi:10.1111/den.70212

BibTeX
@article{Lisotti2026,
  author = {Lisotti, Andrea and Tacelli, Matteo and Crinò, Stefano Francesco and Masciangelo, Graziella and Fusaroli, Pietro and Barthet, Marc and Thosani, Nirav and Conti Bellocchi, Maria Cristina and Leblanc, Sarah and Khoury, Tawfik and Arcidiacono, Paolo Giorgio and Facciorusso, Antonio and Caillol, Fabrice and Giovannini, Marc and Fuccio, Lorenzo and Samanta, Jayanta and Teoh, Anthony Y B and Ogura, Takeshi and Havre, Roald Flesland and Krishna, Somashekar G and Kovacevic, Bojan and Dhir, Vinay and Vilmann, Peter and Lakhtakia, Sundeep and Napoléon, Bertrand and Pham, Khanh Do-Cong and EUS‐RFA methodology study group, EUS‐RFA methodology study group},
  title = {Methodology Assessment of Endoscopic Ultrasound Radiofrequency Ablation ( EUS ‐ RFA ) for Pancreatic Neoplasms: Results From an International Survey},
  journal = {Digestive Endoscopy},
  year = {2026},
  doi = {10.1111/den.70212}
}
Kostenlos starten →